STIM
Neuronetics Inc
2.90$
-1.0%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 34.2% | 22.4% | 24.9% | 26.0% | 24.4% | 33.8% | 50.8% | 53.4% | 54.1% | 48.0% | 53.1% | 48.9% | 50.9% | |
| 65.8% | 77.6% | 75.1% | 74.0% | 75.6% | 66.2% | 49.2% | 46.6% | 45.9% | 52.0% | 46.9% | 51.1% | 49.1% | |
| 12.0% | 10.9% | 13.5% | 13.6% | 13.0% | 25.7% | 5.1% | 4.7% | 4.0% | 4.0% | 4.0% | 3.2% | 3.8% | |
| 35.4% | 30.9% | 34.2% | 37.4% | 40.1% | 47.9% | 41.1% | 31.9% | 29.7% | 31.9% | 37.9% | 27.4% | 31.5% | |
| 115.4% | 99.4% | 114.5% | 125.8% | 117.3% | 117.2% | 83.7% | 67.7% | 65.5% | 64.0% | 73.0% | 54.7% | 63.9% | |
| -49.6% | -21.8% | -39.4% | -51.7% | -41.7% | -51.0% | -34.4% | -21.1% | -19.6% | -12.1% | -26.1% | -3.6% | -14.7% | |
| 6.6% | 9.1% | 10.5% | 12.0% | 9.3% | 7.1% | 6.0% | 5.2% | 5.6% | 5.0% | 6.6% | 5.1% | 5.5% | |
| -52.5% | -26.4% | -45.2% | -59.8% | -72.0% | -56.6% | -39.7% | -25.9% | -25.2% | -17.2% | -31.3% | -8.3% | -19.9% | |
| 10.3% | -35.4% | 3.0% | – | – | – | – | – | – | – | – | – | – | |
| -52.5% | -26.5% | -45.2% | -59.8% | -72.0% | -56.3% | -39.6% | -26.6% | -24.3% | -17.1% | -31.3% | -8.3% | -19.6% | |
| -43.1% | -17.9% | -31.5% | -44.4% | -59.9% | -47.5% | -30.8% | -18.8% | -17.3% | -10.3% | -22.6% | -6.5% | -13.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.